Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
NCT06136546
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Depressive Disorder, Major
Inflammation
Interventions
DRUG:
Infliximab
OTHER:
Placebo
Sponsor
Massachusetts General Hospital